Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 May 4:101263. Online ahead of print. doi: 10.1016/j.imu.2023.101263

Corrigendum to ‟Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsˮ [Inform. Med. Unlocked 23 (2021) 1-9/100541]

Soodeh Mahdian a, Mahboobeh Zarrabi b,, Yunes Panahi c, Somayyeh Dabbagh Sadeghpour b
PMCID: PMC10158040  PMID: 37362152

Unfortunately, I was not careful enough in checking the proof of the article and my address has some problems. I request you to add the amendment to the original article.

Thank you very much for your cooperation.


Articles from Informatics in Medicine Unlocked are provided here courtesy of Elsevier

RESOURCES